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Background/Aims: Dietary supplementation with 2.0-2.5 g per day of
phytosterols (PS) is well known to reduce LDL cholesterol levels by 10-15%.
The most common form of PS-enriched food products are the fat
(margarine) spreads. The predominant fat used in these spreads is either
soybean/sunﬂower (SS) or rapeseed/canola (RC) oils. This study aimed to
investigate whether the carrier fat is a determinant of the hypo-
cholesterolaemic effects of PS-enriched spreads.
Methods: Four databases (Medline, Cochrane, Embase, CINAHL) were
searched using relevant search terms. Published RCTs from 1990 investi-
gating the effects of dietary PS intervention ( 1.5 g per day) on plasma
total (TC) and LDL cholesterol were included. Duplicates (n ¼ 1177) were
removed. Methodological quality of articles was assessed by two inde-
pendent researchers using the Academy of Nutrition and Dietetics’ Quality
Criteria Checklist. Data extracted using standardised tool (PS dose, dura-
tion, sample size, spread fat type and lipids). Studies grouped by fat type;
meta-analysis conducted.
Results: Of 1484 screened abstracts, a total of 16 RCTs (n¼ 6 SS; n ¼ 10 RC)
were included. 14 studies involved mild to moderate hyper-
cholesterolaemic subjects, and two studies involved normocholester-
olaemic subjects. TC signiﬁcantly reduced by 6% and 8% in SS and RC
studies (respectively; p < 0.05 for both). LDL signiﬁcantly reduced by 8%
and 11% in SS and RC studies (respectively; p < 0.05 for both).
Conclusions: The fat type used for the delivery of PS in fat spreads may be
a determinant of the cholesterol-lowering property of PS.
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Background/Aims: Fat taste sensitivity is impaired in obese individuals
and is associated with consumption of dietary fat. Increasing sensitivity to
fats throughout the alimentary canal may be an effective strategy to ach-
ieve sustainable weight loss. This study assessed the effect of a six-week
low-fat diet or portion control diet matched for weight loss on fat taste
thresholds, fat perception and food preference in overweight or obese
people.
Methods: Participants (n ¼ 53; BMI 31.0 ± 0.7 kg/m2) were randomised to
a six-week low-fat diet (25% total fat) or portion control diet (33% total fat).
Anthropometry, fat taste thresholds (lowest detectable fat concentration),
fat perception (discrimination ability) and preference were assessed at
baseline and week six.
Results: Consumption of a low-fat diet (n ¼ 26) and portion control diet (n
¼ 27) reduced participant’s weight (p < 0.001) with no signiﬁcant differ-
ences between groups. Both diets resulted in a decrease in fat taste
thresholds (increased fat taste sensitivity) (p ¼ 0.014), with a trend for a
stronger effect in the low-fat diet versus the portion control diet (p ¼
0.060). The ability to perceive fat in foods was increased in the low-fat diet
group only (p ¼ 0.017), however preference for the level of fat in foods did
not change.
Conclusions: A low-fat and portion control diet both increased fat taste
sensitivity in overweight or obese people, with the strongest effect in the
low-fat diet group. This increase in fat taste sensitivity may help induce a
healthy satiety response to dietary fat and in turn reduce excess energy
intake and weight gain.
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Background/Aims: Long chain omega-3 poly-unsaturated fatty acids (LCn-
3PUFA) are beneﬁcial for several inﬂammatory conditions. We evaluated
the clinical efﬁcacy of ﬁsh oil supplementation as an adjunct to standard
therapy for advanced chronic periodontitis.
Methods: Participants with advanced chronic periodontitis (10M/23F,
mean age 52 ± 10 years) were randomised to consume ﬁsh oil capsules
providing 1884 mg LCn-3PUFA/day (n ¼ 23) or placebo capsules providing
2000 mg soy oil/day (n ¼ 10) for 4 months in a randomised parallel study
design. Patients were assessed at baseline and after 4 months for clinical
outcomes, viz. probing pocket depth (PPD) and clinical attachment (CAL),
and fasting blood samples were assessed for LCn-3PUFA erythrocyte
content and plasma C reactive protein (CRP). In addition dietary intake of
LCn-3PUFA was assessed using a validated food frequency questionnaire.
Results: Erythrocyte LCn-3PUFA increased by 50% in the ﬁsh oil supple-
mented group with no change in the placebo group. There were no
changes in dietary consumption of LCn-3PUFA in either group indicating
good compliance with supplementation. Both groups had improvements
in clinical outcomes, with signiﬁcant reductions in PPD and CAL gain.
There was no signiﬁcant difference between groups in the percentage of
sites that had  2 mm gain of CAL (p ¼ 0.229) or reduction in PPD (p ¼
0.264) after 4 months and there was no signiﬁcant change in plasma CRP
levels in either group.
Conclusions: Whilst periodontal treatment was effective in all partici-
pants, no additional beneﬁt was observed with ﬁsh oil supplementation
for 4 months.
Funding source(s): Australian Dental Research Foundation grants; Nova-
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Background/Aims: There is a paucity of evidence to guide clinicians about
appropriate nutritional management strategies for obese Chronic
Obstructive Pulmonary Disease (COPD) patients. This study aimed to a)
characterise nutritional biomarkers in obese COPD participants, and b)
evaluate changes in nutritional biomarkers following a weight-loss inter-
vention in obese COPD participants.
Methods: Nutritional biomarkers, plasma fatty acids (FAs) and caroten-
oids, were analysed using GC and HPLC respectively and compared in 10
healthy weight and 39 obese COPD adults. Of the obese COPD participants,
28 completed a weight-loss intervention. Changes in diet quality were
examined using 4-day food records and nutritional biomarkers. Predictors
of weight-loss were examined using multiple linear regression.
Results: Therewas a trend towards higher total plasma FAs (p¼ 0.052) and
carotenoids (p ¼ 0.094) in the obese group. Following the weight-loss
intervention, signiﬁcant decreases in total (p ¼ 0.009) and saturated (p ¼
0.037) fat intake, and corresponding decreases in total (p ¼ 0.007) and
saturated (p ¼ 0.003) plasma FAs were observed. There was a trend to-
wards higher total plasma carotenoids post-intervention (p ¼ 0.078), with
